5Winte RJ,Bholasing R,Lijmer JG,et al.Independent prognostic value of C Reactive Protein and tropnin I in patients with unstable angina or non-Q-wave myocardial infarction.Candiovasc Res,1999,40 (1):240-250.
6Ridker PM,Morrow D,MPH.High-Sensitivity C-Reactive Protein and cardiovascular risk rationale for screening and primary prevention.Am J Cardiol,2003,92 (Suppl):17-22.
4Raymond G. C-reactive protein undervalued, underutilized [J]. Clin Chem, 1997,43(11):2017.
5Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men [J]. Am J Cardiol, 1999,84(9) : 1018- 1022.
6Maseri A. Inflammation, atherosclerosis, and ischemic eventsexploring the hidden side of the moon [J]. N Engl J Med, 1997, 336:1014-1016.
8Lagrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction[J]. Circulation, 1997,95 (1): 97- 103.
9Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein [J]. Circulation, 2002,105(16) : 1890- 1896.
10Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular-risk factors: a population based cross sectional study [J]. BMJ, 1996,312 : 1061- 1065.
